February 28, 2007 (San Diego) — Combined therapy with the inhaled corticosteroid budesonide and the long-acting beta-agonist formoterol ( Symbicort) produces bronchodilation as rapidly as does ...
If budesonide-formoterol were to become available over the counter (OTC) and used as-needed for mild asthma, it would save lives and cut healthcare costs, according to a computer modeling study ...
London, UK, Thursday 23 March 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing ...
When used as needed, the combination of budesonide-formoterol was found to be superior to albuterol for the prevention of asthma exacerbations in patients with mild asthma. When used as needed, the ...
The trial met its primary endpoint demonstrating that PT010 reduced the rate of moderate or severe COPD exacerbations by 24% compared with PT003 (rate ratio, 0.76; 95% confidence interval [CI], 0.69–0 ...
Please provide your email address to receive an email when new articles are posted on . DALLAS — Single combination inhaler treatment with budesonide-formoterol on an as-needed basis, compared with ...
PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ -- Viatris Inc (VTRS). (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ ...
Concerns remain about the safety of adding long-acting β 2-agonists to inhaled glucocorticoids for the treatment of asthma. In a postmarketing safety study mandated by the Food and Drug Administration ...
What are the warnings and precautions for Budesonide and Formoterol? • Caution should be exercised in patients with history of heart disease or high blood pressure, epilepsy, diabetes, tuberculosis, ...
Asthma-inhaler-resize_G_514410525 The SYGMA trials assessed the use of an as-needed combined corticosteroid/beta-agonist inhaler in patients with mild asthma. Level 2 ...
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...
Patients with severe COPD treated with budesonide added to either formoterol and/or a short acting bronchodilator have a reduced risk of mortality For severe COPD patients treated with budesonide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results